BioDevice Partnering Conference Spurs Medtech-Biotech Cross Sector Collaborations to Develop Next Generation Medical Devices

BioDevice Partnering: The second annual BioDevice Partnering
conference held in Zurich, Switzerland drew to a close yesterday,
after bringing together 350 deal- and decision- makers from a
technologically converging medical device industry. The conference
generated over 800 one-on-one partnering meetings among the attendees.

Over a two-day period, many delegates identified new business
opportunities and established strategic cross sector relationships to
develop next generation medical devices. BioDevice Partnering is
clearly becoming an important business development event for a broad
range of biomedical technologies. The success of this conference
proves the need for a progressive meeting, such as this one, that
creates meaningful interaction between the biotech and medtech
industries. These cross sector collaborations will prove vital to the
sustained success of the healthcare industry and getting innovative
life saving technologies to market.

In this highly competitive and rapidly globalizing industry,
successful partnering strategies help companies gain access to new
markets, funding, accelerate internal development programs and
identify new intellectual property for acquisition. BioDevice
Partnering, like EBD conferences BIO-Europe and BIO-Europe Spring, use
the Group's proprietary state-of-the-art web-based partnering platform
enabling firms from every part of the industry value-chain to quickly
identify, engage and enter into strategic relationships that drive
their business successfully forward.

BioDevice Partnering is organized by EBD Group in partnership with
Eucomed, the European medical technology industry association.

About EBD Group

EBD Group is the leading partnering firm for the global life
sciences industry. Since 1993, numerous firms have leveraged EBD
Group's partnering conferences, technology and services to identify
business opportunities and develop strategic relationships that drive
their business.

EBD Group's conferences (run in collaboration with leading
industry partners and international trade associations such as BIO and
Eucomed) include BIO-Europe, the world's largest stand-alone life
science partnering conference; BIO-Europe Spring; the investor
conference, BioEquity Europe (co-organized with BioCentury
Publications); and the convergent medical technology partnering
conference, BioDevice Partnering. EBD Group's novel, web-based,
partnering software system is also used at numerous third-party events
around the world. Outside of the conference format, EBD Group's
consultants can provide hands-on assistance for firms seeking to in-
or out-license products and technologies.

EBD Group has offices in San Diego, Munich and London. For more
information visit www.ebdgroup.com

About Eucomed

Eucomed is the Voice of the medical technology industry in Europe.
Eucomed represents directly and indirectly 4500 designers,
manufacturers and suppliers of medical technology used in the
diagnosis, prevention, treatment and amelioration of disease and
disability. Small and medium sized companies make up more than 80% of
this sector. The European medical technology industry invests some EUR
3,8 billion in R&D and employs near to 435.000 highly skilled workers.
The mission of Eucomed is to improve patient and clinician access to
modern, innovative and reliable medical technology.